L'entreprise est à nous…

International audienceQuand on se demande si « l’entreprise est à nous », encore faut-il définir quel groupe se cache derrière le « nous »… Ce même slogan peut en effet être scandé par des travailleurs ou des actionnaires. Derrière cette lutte relative à la revendication d’un droit de propriété sur l’entreprise, on retrouverait le conflit entre le travail et le capital. Or, force est de constater que, ces dernières décennies, c’est le point de vue actionnarial qui domine celui des travailleurs (Favereau, 2014)

Systèmes catalytiques pour la photosynthèse artificielle : optimisation par l'application des concepts du design moléculaire en chimie de coordination

Dans le contexte éco-environnemental actuel, l’Humanité est à la recherche d’alternatives pour remplacer les carburants fossiles responsables du changement climatique affectant le quotidien un peu plus chaque année. Inspiré par la Nature et le processus de la photosynthèse, un nouveau domaine à l’interface entre chimie, physique et ingénierie émergea dans les années 70 : la photosynthèse artificielle. Depuis, de nombreux systèmes catalytiques ont été rapportés mais leur intégration à l’échelle commerciale n’est pas encore d’actualité. De nombreux défis demeurent afin d’améliorer les performances, coupler les différentes réactions et s’assurer de la stabilité à long terme des dispositifs. Dans le cadre de cette thèse de doctorat, nous nous sommes attachés à explorer la chimie de coordination de complexes de ruthénium et de rhénium, omniprésents dans la littérature mais dont les propriétés peuvent être encore largement modulées par le design de nouveaux ligands. Dans un deuxième temps, les polyoxométallates, composés inorganiques à mi-chemin entre oxydes et molécules aux propriétés fascinantes, ont été recrutés pour développer des dyades covalentes, stratégie permettant de stabiliser un chromophore dans les conditions photocatalytiques.In the current ecological and environmental context, Mankind needs to find alternative energy sources to replace fossil fuels, as their combustion is a major cause of the current global climate change affecting our daily life a bit more each year. Inspired by Nature and the photosynthetic process, a new area at the interface between chemistry, physics and engineering has emerged in the 70s: artificial photosynthesis. Since then, many catalytic systems have been reported but their integration at commercial scale has not yet been achieved. Several challenges remain to improve their performances, ensure efficient coupling between the different reactions and enhance the long-term stability of these devices. Within this doctoral thesis, we have focused on exploring the coordination chemistry of ruthenium and rhenium complexes, ubiquitous in the literature though their properties can still be vastly tuned by designing new ligands. In a different approach, polyoxometalates, which are inorganic compounds half-way between oxides and molecules with fascinating properties, were recruited to develop covalent dyads, a strategy enabling stabilization of the dye under photocatalytic conditions

Second-line targeted therapies after nivolumab-ipilimumab failure in metastatic renal cell carcinoma

Correction: Volume: 119 Pages: 200-201 DOI: 10.1016/j.ejca.2019.04.012 Published: SEP 2019Background: Nivolumab-ipilimumab demonstrated a survival benefit over sunitinib in first-line setting for metastatic renal cell carcinomas (mRCCs) and is becoming a new standard of care for naive patients with intermediate or poor risk prognosis (International mRCC Database Consortium). The efficacy of subsequent vascular endothelial growth factor receptor tyrosine kinase inhibitors (TKIs) after nivolumab-ipilimumab failure remains unclear. Methods: Medical records of mRCC patients treated with nivolumab-ipilimumab, who received subsequent TKI, as part of Checkmate 214 study were reviewed in 13 institutions. Baseline characteristics, outcome data including progression-free survival (PFS), response, overall survival (OS) and toxicities were retrospectively collected. Results: Overall 33 patients received subsequent TKI after nivolumab-ipilimumab failure. Median follow-up from start of subsequent TKI is 22 months (19-NR). Best response was assessed in 30 patients: 12 partial responses (36%), 13 stable diseases (39%) and five progressive diseases (15%). Median PFS from start of TKI was 8 months [5-13]. Median PFS with first-generation (sunitinib/pazopanib) and second-generation TKI (axitinib/cabozantinib) was 8 months [5-16] and 7 months (5-NA), respectively. PFS in second line was significantly longer in patients with a long first-line duration of response to the double immune checkpoint blockade (>= 6 months) with 8 versus 5 months for short responder (= 3. Conclusion: This is the first report of outcomes with TKI, after first-line nivolumab-ipilimumab failure. Median PFS suggests a sustained benefit of TKI and supports trials investigating the optimal sequence. (C) 2018 Published by Elsevier Ltd.Peer reviewe

The HOXB4 Homeoprotein Promotes the Ex Vivo Enrichment of Functional Human Embryonic Stem Cell-Derived NK Cells

Human embryonic stem cells (hESCs) can be induced to differentiate into blood cells using either co-culture with stromal cells or following human embryoid bodies (hEBs) formation. It is now well established that the HOXB4 homeoprotein promotes the expansion of human adult hematopoietic stem cells (HSCs) but also myeloid and lymphoid progenitors. However, the role of HOXB4 in the development of hematopoietic cells from hESCs and particularly in the generation of hESC-derived NK-progenitor cells remains elusive. Based on the ability of HOXB4 to passively enter hematopoietic cells in a system that comprises a co-culture with the MS-5/SP-HOXB4 stromal cells, we provide evidence that HOXB4 delivery promotes the enrichment of hEB-derived precursors that could differentiate into fully mature and functional NK. These hEB-derived NK cells enriched by HOXB4 were characterized according to their CMH class I receptor expression, their cytotoxic arsenal, their expression of IFNγ and CD107a after stimulation and their lytic activity. Furthermore our study provides new insights into the gene expression profile of hEB-derived cells exposed to HOXB4 and shows the emergence of CD34+CD45RA+ precursors from hEBs indicating the lymphoid specification of hESC-derived hematopoietic precursors. Altogether, our results outline the effects of HOXB4 in combination with stromal cells in the development of NK cells from hESCs and suggest the potential use of HOXB4 protein for NK-cell enrichment from pluripotent stem cells

HpaC Controls Substrate Specificity of the Xanthomonas Type III Secretion System

The Gram-negative bacterial plant pathogen Xanthomonas campestris pv. vesicatoria employs a type III secretion (T3S) system to inject bacterial effector proteins into the host cell cytoplasm. One essential pathogenicity factor is HrpB2, which is secreted by the T3S system. We show that secretion of HrpB2 is suppressed by HpaC, which was previously identified as a T3S control protein. Since HpaC promotes secretion of translocon and effector proteins but inhibits secretion of HrpB2, HpaC presumably acts as a T3S substrate specificity switch protein. Protein–protein interaction studies revealed that HpaC interacts with HrpB2 and the C-terminal domain of HrcU, a conserved inner membrane component of the T3S system. However, no interaction was observed between HpaC and the full-length HrcU protein. Analysis of HpaC deletion derivatives revealed that the binding site for the C-terminal domain of HrcU is essential for HpaC function. This suggests that HpaC binding to the HrcU C terminus is key for the control of T3S. The C terminus of HrcU also provides a binding site for HrpB2; however, no interaction was observed with other T3S substrates including pilus, translocon and effector proteins. This is in contrast to HrcU homologs from animal pathogenic bacteria suggesting evolution of distinct mechanisms in plant and animal pathogenic bacteria for T3S substrate recognition

Learning new sensorimotor contingencies:Effects of long-term use of sensory augmentation on the brain and conscious perception

Theories of embodied cognition propose that perception is shaped by sensory stimuli and by the actions of the organism. Following sensorimotor contingency theory, the mastery of lawful relations between own behavior and resulting changes in sensory signals, called sensorimotor contingencies, is constitutive of conscious perception. Sensorimotor contingency theory predicts that, after training, knowledge relating to new sensorimotor contingencies develops, leading to changes in the activation of sensorimotor systems, and concomitant changes in perception. In the present study, we spell out this hypothesis in detail and investigate whether it is possible to learn new sensorimotor contingencies by sensory augmentation. Specifically, we designed an fMRI compatible sensory augmentation device, the feelSpace belt, which gives orientation information about the direction of magnetic north via vibrotactile stimulation on the waist of participants. In a longitudinal study, participants trained with this belt for seven weeks in natural environment. Our EEG results indicate that training with the belt leads to changes in sleep architecture early in the training phase, compatible with the consolidation of procedural learning as well as increased sensorimotor processing and motor programming. The fMRI results suggest that training entails activity in sensory as well as higher motor centers and brain areas known to be involved in navigation. These neural changes are accompanied with changes in how space and the belt signal are perceived, as well as with increased trust in navigational ability. Thus, our data on physiological processes and subjective experiences are compatible with the hypothesis that new sensorimotor contingencies can be acquired using sensory augmentation

Roadmap on dynamics of molecules and clusters in the gas phase

This roadmap article highlights recent advances, challenges and future prospects in studies of the dynamics of molecules and clusters in the gas phase. It comprises nineteen contributions by scientists with leading expertise in complementary experimental and theoretical techniques to probe the dynamics on timescales spanning twenty order of magnitudes, from attoseconds to minutes and beyond, and for systems ranging in complexity from the smallest (diatomic) molecules to clusters and nanoparticles. Combining some of these techniques opens up new avenues to unravel hitherto unexplored reaction pathways and mechanisms, and to establish their significance in, e.g. radiotherapy and radiation damage on the nanoscale, astrophysics, astrochemistry and atmospheric science

Blue-green emissive cationic iridium(III) complexes using partially saturated strongly-donating guanidyl-pyridine/pyrazine ancillary ligands

The authors are grateful to the Natural Sciences and Engineering Research Council (NSERC) of Canada, le Fonds québécois de la recherche sur la nature et les technologies (FRQNT), the Centre for Self Assembled Chemical Structures (CSACS), the Centre in Green Chemistry and Catalysis (CCVC), and the Université de Montréal (UdeM) for financial support. EZ-C acknowledges the University of St Andrews for financial support.A new class of cationic iridium(III) complexes of the form [(C^N)2Ir(N^N)][PF6] is reported, where C^N = cyclometallating 2-phenylpyridinato, ppy, or 2-(2,4-difluorophenyl)-5′-methylpyridinato, dFMeppy, and N^N = guanidyl-pyridine, gpy, or pyrazine, gpz, as the ancillary ligand. A large blue-shift in the emission coupled with a 7-to-9 fold enhancement in photoluminescence quantum yield and microsecond emission lifetimes were observed for the complexes containing the partially saturated gpy ligand as compared to the benchmark complex [(ppy)2Ir(bpy)][PF6], C1, where bpy is 2,2′-bipyridine.Publisher PDFPeer reviewe